Analyst Activity – HC Wainwright Initiates Coverage On Ocular Therapeutix (NASDAQ:OCUL) With a Buy

ME Staff
-
0

Analyst Ratings For Ocular Therapeutix (NASDAQ:OCUL)

Today, HC Wainwright initiated coverage on Ocular Therapeutix (NASDAQ:OCUL) with a Buy with a price target of $10.00.

There are 2 hold ratings, 5 buy ratings on the stock.

The current consensus rating on Ocular Therapeutix (NASDAQ:OCUL) is Buy (Score: 2.71) with a consensus target price of $21.41 per share, a potential 233.42% upside.

Some recent analyst ratings include

  • 7/26/2017-HC Wainwright initiated coverage with a Buy rating.
  • 7/17/2017-BTIG Research Reiterated Rating of Neutral.
  • 7/14/2017-Morgan Stanley Reiterated Rating of Equal Weight.
  • 3/13/2017-Cowen and Company Reiterated Rating of Outperform.
  • 11/15/2016-Royal Bank Of Canada Reiterated Rating of Outperform.
  • 8/11/2016-JMP Securities initiated coverage with a Outperform rating.

Recent Insider Trading Activity For Ocular Therapeutix (NASDAQ:OCUL)
Ocular Therapeutix (NASDAQ:OCUL) has insider ownership of 26.10% and institutional ownership of 65.21%.

  • On 12/15/2016 Amarpreet Sawhney, Insider, bought 45,300 with an average share price of $7.85 per share and the total transaction amounting to $355,605.00. View SEC Filing
  • On 6/9/2016 Amarpreet Sawhney, CEO, bought 10,000 with an average share price of $6.70 per share and the total transaction amounting to $67,000.00. View SEC Filing
  • On 11/17/2015 Amarpreet Sawhney, CEO, bought 10,000 with an average share price of $8.25 per share and the total transaction amounting to $82,500.00. View SEC Filing
  • On 9/15/2015 James Fortune, COO, sold 9,470 with an average share price of $17.16 per share and the total transaction amounting to $162,505.20. View SEC Filing
  • On 9/14/2015 Amarpreet Sawhney, CEO, bought 15,000 with an average share price of $16.50 per share and the total transaction amounting to $247,500.00. View SEC Filing
  • On 6/15/2015 Charles M Warden, Director, sold 320,000 with an average share price of $22.00 per share and the total transaction amounting to $7,040,000.00. View SEC Filing
  • On 6/10/2015 Charles M Warden, Director, sold 427,000 with an average share price of $22.00 per share and the total transaction amounting to $9,394,000.00. View SEC Filing

Recent Trading Activity for Ocular Therapeutix (NASDAQ:OCUL)
Shares of Ocular Therapeutix closed the previous trading session at 6.42 down -0.19 -2.87% with 556,062 shares trading hands.